A randomized, double-blind, single and multiple ascending dose phase I trial of Tobrate in healthy volunteers

Trial Profile

A randomized, double-blind, single and multiple ascending dose phase I trial of Tobrate in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Tobramycin (Primary)
  • Indications Urinary tract infections
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 13 Jul 2016 According to an Enteris BioPharna media release, data from this trail is expected in the first quarter of 2017.
    • 13 Jul 2016 According to an Enteris BioPharna media release, the US FDA has accepted an Investigational New Drug (IND) application for Tobrate clinical program.
    • 13 Jul 2016 According to an Enteris BioPharna media release, status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top